Login
Home
Charts
Search
Watchlist
Products

Chandan Healthcare Ltd

CHANDAN·NSE
₹222.55-1.64%Wed, 23 Sept '26
Industry:Diagnostic Services
Indices:

Chandan Healthcare Ltd

CHANDAN
NSE
₹222.55
-1.64%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Diagnostic Services
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹544Cr
Close
Close Price
₹222.55
Industry
Industry
Diagnostic Services
PE
Price To Earnings
21.97
PS
Price To Sales
1.88
Revenue
Revenue
₹289Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
—

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
55636868657681
Growth YoY
Revenue Growth YoY%
19.020.619.1
Expenses
ExpensesCr
46525454536461
Operating Profit
Operating ProfitCr
9101414121120
OPM
OPM%
16.316.320.420.818.215.224.2
Other Income
Other IncomeCr
0211-121
Interest Expense
Interest ExpenseCr
1111125
Depreciation
DepreciationCr
1342244
PBT
PBTCr
7910117812
Tax
TaxCr
2333234
PAT
PATCr
5668558
Growth YoY
PAT Growth YoY%
8.6-19.028.0
NPM
NPM%
8.59.79.112.27.76.59.8
EPS
EPS₹
2.12.62.43.21.92.03.1
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
55636868657681
Growth YoY
Revenue Growth YoY%
19.020.619.1
Expenses
ExpensesCr
46525454536461
Operating Profit
Operating ProfitCr
9101414121120
OPM
OPM%
16.316.320.420.818.215.224.2
Other Income
Other IncomeCr
0211-121
Interest Expense
Interest ExpenseCr
1111125
Depreciation
DepreciationCr
1342244
PBT
PBTCr
7910117812
Tax
TaxCr
2333234
PAT
PATCr
5668558
Growth YoY
PAT Growth YoY%
8.6-19.028.0
NPM
NPM%
8.59.79.112.27.76.59.8
EPS
EPS₹
2.12.62.43.21.92.03.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
87120137177230276289
Growth
Revenue Growth%
37.214.529.030.320.1
Expenses
ExpensesCr
82117128150190224232
Operating Profit
Operating ProfitCr
52926405357
OPM
OPM%
5.71.96.814.917.619.019.7
Other Income
Other IncomeCr
0001313
Interest Expense
Interest ExpenseCr
2223569
Depreciation
DepreciationCr
222371013
PBT
PBTCr
2-1521323837
Tax
TaxCr
101591011
PAT
PATCr
1-1416242926
Growth
PAT Growth%
-223.3428.3356.143.821.4
NPM
NPM%
1.0-0.92.69.310.210.39.0
EPS
EPS₹
0.4-0.61.78.110.87.910.1
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
87120137177230276289
Growth
Revenue Growth%
37.214.529.030.320.1
Expenses
ExpensesCr
82117128150190224232
Operating Profit
Operating ProfitCr
52926405357
OPM
OPM%
5.71.96.814.917.619.019.7
Other Income
Other IncomeCr
0001313
Interest Expense
Interest ExpenseCr
2223569
Depreciation
DepreciationCr
222371013
PBT
PBTCr
2-1521323837
Tax
TaxCr
101591011
PAT
PATCr
1-1416242926
Growth
PAT Growth%
-223.3428.3356.143.821.4
NPM
NPM%
1.0-0.92.69.310.210.39.0
EPS
EPS₹
0.4-0.61.78.110.87.910.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
202020202424
Reserves
ReservesCr
4472198145
Current Liabilities
Current LiabilitiesCr
334557585777
Non Current Liabilities
Non Current LiabilitiesCr
81011172836
Total Liabilities
Total LiabilitiesCr
658298118211290
Current Assets
Current AssetsCr
37435461110165
Non Current Assets
Non Current AssetsCr
28384557100125
Total Assets
Total AssetsCr
658298118211290
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
202020202424
Reserves
ReservesCr
4472198145
Current Liabilities
Current LiabilitiesCr
334557585777
Non Current Liabilities
Non Current LiabilitiesCr
81011172836
Total Liabilities
Total LiabilitiesCr
658298118211290
Current Assets
Current AssetsCr
37435461110165
Non Current Assets
Non Current AssetsCr
28384557100125
Total Assets
Total AssetsCr
658298118211290

Cash Flow

Consolidated
Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
651-316
Investing Cash Flow
Investing Cash FlowCr
-11-6-15-62-40
Financing Cash Flow
Financing Cash FlowCr
32166721
Net Cash Flow
Net Cash FlowCr
-1022-3
Free Cash Flow
Free Cash FlowCr
-1-1-18-41-26
CFO To PAT
CFO To PAT%
-558.3125.46.8-11.756.6
CFO To EBITDA
CFO To EBITDA%
270.648.04.2-6.830.8
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
651-316
Investing Cash Flow
Investing Cash FlowCr
-11-6-15-62-40
Financing Cash Flow
Financing Cash FlowCr
32166721
Net Cash Flow
Net Cash FlowCr
-1022-3
Free Cash Flow
Free Cash FlowCr
-1-1-18-41-26
CFO To PAT
CFO To PAT%
-558.3125.46.8-11.756.6
CFO To EBITDA
CFO To EBITDA%
270.648.04.2-6.830.8

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
443536544
Price To Earnings
Price To Earnings
20.019.822.0
Price To Sales
Price To Sales
1.91.91.9
Price To Book
Price To Book
3.63.23.2
EV To EBITDA
EV To EBITDA
12.011.210.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.846.650.952.050.748.348.3
OPM
OPM%
5.71.96.814.917.619.019.7
NPM
NPM%
1.0-0.92.69.310.210.39.0
ROCE
ROCE%
9.81.615.331.421.519.719.7
ROE
ROE%
3.7-4.613.139.719.216.816.8
ROA
ROA%
1.4-1.33.613.811.29.99.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
443536544
Price To Earnings
Price To Earnings
20.019.822.0
Price To Sales
Price To Sales
1.91.91.9
Price To Book
Price To Book
3.63.23.2
EV To EBITDA
EV To EBITDA
12.011.210.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
41.846.650.952.050.748.348.3
OPM
OPM%
5.71.96.814.917.619.019.7
NPM
NPM%
1.0-0.92.69.310.210.39.0
ROCE
ROCE%
9.81.615.331.421.519.719.7
ROE
ROE%
3.7-4.613.139.719.216.816.8
ROA
ROA%
1.4-1.33.613.811.29.99.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Chandan Healthcare Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/53f2wqjidj6wvxahpvz07o02.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/crj2sh8zpvhykdlhd4zfqv7u.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/w0k4vu4tuh04z2sltpw0vjy2.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/qev5j02nbwggonpim45uiyso.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/93tpa3pt7y5lki9gfgr56opn.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/9axoqe6cjzgkyispr14k3cps.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/pmh8sfgqvikhy4pf0njh0im4.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/h5gl411ersdc3qymqowq6170.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/mzrgdtesixnsxxm16him5pgg.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/2fng254c57fkcc57gig786mo.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/jm2xacoetqubotjm05v9giyd.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/yctg5x7s6p0e9shc1sx65bio.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/i4k0hyyg690rppft3kwpedth.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/hzxtww5lcmxlt5966w8qq0g9.pdf

Concall Transcript Summaries — Chandan Healthcare Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ACHANDAN/transcript-notes/202606/53f2wqjidj6wvxahpvz07o02.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ACHANDAN/transcript-notes/202603/crj2sh8zpvhykdlhd4zfqv7u.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ACHANDAN/transcript-notes/202512/w0k4vu4tuh04z2sltpw0vjy2.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ACHANDAN/transcript-notes/202509/qev5j02nbwggonpim45uiyso.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies